BCLI Stock DD BrainStorm Cell Therapeutics Inc. 08/06/2014 12:42:42

Message Board

Previous

| Next

Post# of 250673

Posted On: 08/06/2014 1:42:45 PM

Posted By: Rosner

BCLI BrainStorm Cell Therapeutics Inc. $BCLI Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=BCLI&...mp;yt0=Go!

Last Updated: 08/06/2014 12:42:37

Current Price and Quotes
Last Price 0.3155
Previous Close 0.305 Open 0.315
Daily Range 0.307 - 0.318 52wk Range 0.1026 - 0.38
Volume 347,111 Dividend N/A
Average Vol (3m) 1,145,453 Yield N/A

Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development 2,917 1,770 1,689 1,045
Sales, General and Admin. 2,101 1,748 2,205 1,544
Non-Recurring Items - - - -
Other - - - -
Operating Income (5,018) (3,518) (3,894) (2,589)
Income From Continuing Operations

Add'l Income/Expense Items - - 132 -
Earnings Before Interest and Tax (4,874) (3,425) (3,913) (2,400)
Interest Expense - - - -
Earnings Before Tax (4,874) (3,425) (3,913) (2,400)
Income Tax 25 5 5 19
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,899) (3,430) (3,918) (2,419)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,899) (3,430) (3,918) (2,419)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (4,899) (3,430) (3,918) (2,419)

Recent News

Jul 28, 2014 BrainStorm Receives Notice of Allowance on US Patent
Jul 15, 2014 BrainStorm Announces that University of Massachusetts Memorial Medical Center to Begin Enrolling Patients in Phase 2 ALS Clinical Trial
Jul 11, 2014 BrainStorm Announces Publication of Preclinical Multidose Study of NurOwn
Jul 1, 2014 OTC Stocks Daily Trading Focus: Windstream Technologies, Inc. Blue Earth, Inc. Creative Edge Nutrition, Inc. Brainstorm Cell Therapeutics, Inc., Advanced Cell Technology, Inc.
Jun 27, 2014 BrainStorm and Octane Successfully Construct a Bioreactor Prototype for Industrial-Scale Manufacturing or NurOwn Stem Cells
Jun 13, 2014 BrainStorm Cell Therapeutics Raises $10.5 Million in Private Placement Financing
Jun 10, 2014 BrainStorm Expands Pipeline With Initiation of Pre-Clinical Study in Autism
Jun 9, 2014 BrainStorm Cell Therapeutics Appoints Tony Fiorino, MD, PhD as Chief Executive Officer
Jun 6, 2014 First Patient Enrolled in BrainStorm's Phase II ALS Trial at Massachusetts General Hospital
Jun 5, 2014 BrainStorm Hosting Conference Call to Update Shareholders on Major Developments

1
2
next >

(0)

(0)